Latest News

Scholarship supports the next generation of top researchers.

We would like to congratulate Kolling Institute researcher Amanda Purcell who has received a Juvenile Diabetes Research Foundation scholarship. Amanda is part of our Renal Research Laboratory, working to improve treatment for those with diabetes and kidney disease. She has been awarded a top-up scholarship aimed at supporting PhD students pursuing type 1 diabetes research in line with the foundatio.....
Read more

Category: Awards, Cardiovascular and Renal Research, Research Excellence

Kolling researchers leading the fight against diabetes.

With a concerning rise in the number of people developing Type 2 diabetes, our researchers at the Kolling Institute are offering hope and an effective way forward to reduce the impact of the serious disease. Type 2 diabetes is the fastest growing chronic disease in the world, and if the current trend continues, it’s anticipated close to three million Australians will have the disease by 2025. It of.....
Read more

Category: Cardiovascular and Renal Research, New Treatment, Research Excellence

Technology giving our researchers the edge.

Impressive new infrastructure at the Kolling Institute is set to drive progress with our research into cancer and neuroscience. The equipment includes a digital spatial profiling system, which is regarded as one of the most exciting technological advances globally in the investigation of tissues. The $525,000 instrument has been made possible following a LIEF grant through the Australian Research C.....
Read more

Category: Funding support

Act of generosity continues to deliver hope for those with cancer.

The Kolling Institute hosted a special visit by the family of the late Bill Walsh who donated vital funds to establish a cancer laboratory within the Kolling. His family, including his wife, daughters and grandchildren visited the lab to maintain their strong ties with the research team and meet with Academic Director Professor Jim Elliott. Established in 1980, the Bill Walsh Cancer Research Labora.....
Read more

Category: Funding support, Research Excellence

Technology delivering support to those with back pain anywhere, any time.

With the number of people living with low back pain escalating sharply, researchers are turning to widely-accessible technology to reduce the impact of the disabling condition. The team from the University of Sydney and the Kolling Institute has launched a study measuring the effectiveness of a mobile health program which offers self-management strategies via text messages. Study lead Professor Man.....
Read more

Category: Musculoskeletal Research, New Treatment, Research Excellence

Australian researchers uniquely positioned to support upcoming space missions.

The expertise across Australia’s space medicine community was showcased during a special event co-ordinated by the Kolling Institute and the Australasian Society of Aerospace Medicine. Staged over two days, the colloquium involved national and international experts including representatives from the Australian Space Agency, the CSIRO, Boeing and the Australian Antarctic Program. Presenters discusse.....
Read more

Category: New Treatment, Research Excellence

Kolling Institute Year in Review 2022 .

Check out our Kolling Institute Year in Review 2022 celebrating our research success. It highlights our world-leading translational research and our impact across our priority research areas. Click on the link here.
Read more

Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research

New approach delivers breakthrough for pain researchers.

Researchers at the Kolling Institute have made important progress towards the development of new treatments for chronic pain by identifying a small group of cells which can control pain responses. The breakthrough comes as approximately 20 per cent of the world’s population suffers from chronic pain, including around 3.4 million Australians. Dr Neda Assareh, a neuroscientist research fellow from th.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

Research questions the value of injectable medications for osteoarthritis.

Our researchers at the Kolling Institute are encouraging those with osteoarthritis to rely on treatments with a proven track record and avoid quick fixes without the data to show they work. The comments follow a steady rise in osteoarthritis cases nationally, with around three million Australians now living with the condition, and many forced to retire early. The rise in cases has coincided with st.....
Read more

Category: Musculoskeletal Research, Research Excellence

Back pain cases to rise sharply.

A new study by researchers at the Kolling Institute estimates more than 800 million people will be living with low back pain by 2050, a 36 percent increase from 2020. The prediction follows an analysis of 30 years of global health data from over 200 countries. Modelling shows the number of back pain cases globally will rise to 843 million people by 2050, while in Australia, it’s expected there will.....
Read more

Category: Musculoskeletal Research